Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model.
Journal article published in 2016 by
Matheus Hw W. Crommentuijn 
,
Rami Kantar,
David P. Noske,
W. Peter Vandertop,
Christian E. Badr,
Thomas Würdinger,
Casey A. Maguire ,
Bakhos A. Tannous
,
Rami Kantar,
David P. Noske,
W. Peter Vandertop,
Christian E. Badr,
Thomas Würdinger,
Casey A. Maguire ,
Bakhos A. Tannous
This paper is made freely available by the publisher.
Full text: Download
Data provided by 